Dr. Brian Cole Leads 1st US Study of Stem Cell Treatment for Knee Cartilage Damage

Written by  Laura Dyrda | Friday, 25 January 2013 15:13
Social sharing
Brian Cole, MD, an orthopedic surgeon at Rush University Medical Center, is the principle investigator on the first clinical study of Cartistem in the United States, according to a News-Medical report.
Cartistem is a stem cell therapy designed to repair knee cartilage. It is manufactured from mesenchymal stem cells, according to the report, and mixed with hyaluronan. The two-year study plans to enroll 12 participants.

Dr. Cole is the head of Rush's Cartilage Restoration Center.

More Articles on Orthopedic Surgery:

8 Ideas for Orthopedic Practices to Improve Their Bottom Line

102 Surgeons Focused on Spine Surgery

3B Orthopaedics Surgeons Join Aria Health

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months